361 related articles for article (PubMed ID: 23546875)
21. Dolomiaea souliei ethyl acetate extract protected against α-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid x receptor-mediated bile acid metabolism.
Meng F; Zong W; Wei X; Tao Y; Wang G; Liao Z; Chen M
Phytomedicine; 2021 Jul; 87():153588. PubMed ID: 34091148
[TBL] [Abstract][Full Text] [Related]
22. The amino acid residues asparagine 354 and isoleucine 372 of human farnesoid X receptor confer the receptor with high sensitivity to chenodeoxycholate.
Cui J; Heard TS; Yu J; Lo JL; Huang L; Li Y; Schaeffer JM; Wright SD
J Biol Chem; 2002 Jul; 277(29):25963-9. PubMed ID: 12004058
[TBL] [Abstract][Full Text] [Related]
23. Direct methylation of FXR by Set7/9, a lysine methyltransferase, regulates the expression of FXR target genes.
Balasubramaniyan N; Ananthanarayanan M; Suchy FJ
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G937-47. PubMed ID: 22345554
[TBL] [Abstract][Full Text] [Related]
24. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor.
Honjo Y; Sasaki S; Kobayashi Y; Misawa H; Nakamura H
J Endocrinol; 2006 Mar; 188(3):635-43. PubMed ID: 16522742
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids.
Frankenberg T; Rao A; Chen F; Haywood J; Shneider BL; Dawson PA
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G912-22. PubMed ID: 16357058
[TBL] [Abstract][Full Text] [Related]
26. Ku proteins function as corepressors to regulate farnesoid X receptor-mediated gene expression.
Ohno M; Kunimoto M; Nishizuka M; Osada S; Imagawa M
Biochem Biophys Res Commun; 2009 Dec; 390(3):738-42. PubMed ID: 19833092
[TBL] [Abstract][Full Text] [Related]
27. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.
Landrier JF; Eloranta JJ; Vavricka SR; Kullak-Ublick GA
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G476-85. PubMed ID: 16269519
[TBL] [Abstract][Full Text] [Related]
28. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.
Alvarez L; Jara P; Sánchez-Sabaté E; Hierro L; Larrauri J; Díaz MC; Camarena C; De la Vega A; Frauca E; López-Collazo E; Lapunzina P
Hum Mol Genet; 2004 Oct; 13(20):2451-60. PubMed ID: 15317749
[TBL] [Abstract][Full Text] [Related]
29. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
Vanwijngaerden YM; Wauters J; Langouche L; Vander Perre S; Liddle C; Coulter S; Vanderborght S; Roskams T; Wilmer A; Van den Berghe G; Mesotten D
Hepatology; 2011 Nov; 54(5):1741-52. PubMed ID: 21800341
[TBL] [Abstract][Full Text] [Related]
30. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
[TBL] [Abstract][Full Text] [Related]
31. Nuclear factor erythroid 2-related factor 2 is a positive regulator of human bile salt export pump expression.
Weerachayaphorn J; Cai SY; Soroka CJ; Boyer JL
Hepatology; 2009 Nov; 50(5):1588-96. PubMed ID: 19821532
[TBL] [Abstract][Full Text] [Related]
32. The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes.
Rizzo G; Renga B; Antonelli E; Passeri D; Pellicciari R; Fiorucci S
Mol Pharmacol; 2005 Aug; 68(2):551-8. PubMed ID: 15911693
[TBL] [Abstract][Full Text] [Related]
33. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.
Cai SY; Gautam S; Nguyen T; Soroka CJ; Rahner C; Boyer JL
Gastroenterology; 2009 Mar; 136(3):1060-9. PubMed ID: 19027009
[TBL] [Abstract][Full Text] [Related]
34. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.
Schuetz EG; Strom S; Yasuda K; Lecureur V; Assem M; Brimer C; Lamba J; Kim RB; Ramachandran V; Komoroski BJ; Venkataramanan R; Cai H; Sinal CJ; Gonzalez FJ; Schuetz JD
J Biol Chem; 2001 Oct; 276(42):39411-8. PubMed ID: 11509573
[TBL] [Abstract][Full Text] [Related]
35. Dehydrodiconiferyl alcohol, a lignan from Herpetospermum pedunculosum, alleviates cholestasis by activating pathways associated with the farnesoid X receptor.
Wei X; Ma Y; Dong Z; Wang G; Lan X; Liao Z; Chen M
Phytomedicine; 2021 Jan; 80():153378. PubMed ID: 33113499
[TBL] [Abstract][Full Text] [Related]
36. Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice.
Lee J; Seok S; Yu P; Kim K; Smith Z; Rivas-Astroza M; Zhong S; Kemper JK
Hepatology; 2012 Jul; 56(1):108-17. PubMed ID: 22278336
[TBL] [Abstract][Full Text] [Related]
37. Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding.
Kassam A; Miao B; Young PR; Mukherjee R
J Biol Chem; 2003 Mar; 278(12):10028-32. PubMed ID: 12519787
[TBL] [Abstract][Full Text] [Related]
38. LXR alpha transactivates mouse organic solute transporter alpha and beta via IR-1 elements shared with FXR.
Okuwaki M; Takada T; Iwayanagi Y; Koh S; Kariya Y; Fujii H; Suzuki H
Pharm Res; 2007 Feb; 24(2):390-8. PubMed ID: 17177110
[TBL] [Abstract][Full Text] [Related]
39. Requirement for MLL3 in p53 regulation of hepatic expression of small heterodimer partner and bile acid homeostasis.
Kim DH; Kim J; Lee JW
Mol Endocrinol; 2011 Dec; 25(12):2076-83. PubMed ID: 22034226
[TBL] [Abstract][Full Text] [Related]
40. Antiatherosclerotic effect of farnesoid X receptor.
Mencarelli A; Renga B; Distrutti E; Fiorucci S
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
